ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

NCI CTEP Approved Trials For the Month of April

April 26, 2013

Sandra Horning elected ASCO president-elect.

February 27, 2004

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987

Breast Cancer Plan Issues Its First RFA, Other Initiatives To Be Announced Soon

April 14, 1995

NCCS Selects New President

October 9, 2009